Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - Latest https://ift.tt/2ORjxma

Comments

Popular posts from this blog

"Modi Does What He Promises": PM On Why People Trust His 'Guarantees'

'800-Strong Mob Intended To Cause Death': Probe Agency On Bengal Attack